A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Orally Administered NNZ-2591 Compared with Placebo in Pediatric Participants with Phelan McDermid Syndrome (The KOALA Study)
Researcher(s)
Ontario Location
Holland Bloorview Kids Rehabilitation Hospital | Toronto, Ontario, Canada, M4G 1R8
